BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35448512)

  • 1. Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.
    Glinsky GV; Godugu K; Sudha T; Rajabi M; Chittur SV; Hercbergs AA; Mousa SA; Davis PJ
    Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
    Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
    Bioconjug Chem; 2019 Dec; 30(12):3087-3097. PubMed ID: 31714064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
    Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
    Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α
    Sudha T; Godugu K; Glinsky GV; Mousa SA
    Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Cancer Activities of Thyrointegrin α
    Godugu K; Rajabi M; Mousa SA
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
    Davis PJ; Mousa SA; Lin HY
    Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
    Davis PJ; Lin HY; Hercbergs A; Mousa SA
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Godugu K; Mousa SA; Glinsky GV; Lin HY; Davis PJ
    Front Endocrinol (Lausanne); 2022; 13():745327. PubMed ID: 35311239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
    Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
    Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of Thyroid Hormone to Cancer Metastasis.
    Mousa SA; Glinsky GV; Lin HY; Ashur-Fabian O; Hercbergs A; Keating KA; Davis PJ
    Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30135398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of Thyroid Hormones on Thyroid Cancers.
    Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
    Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrac as an anti-angiogenic agent in cancer.
    Schmohl KA; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
    Sudha T; Bharali DJ; Sell S; Darwish NHE; Davis PJ; Mousa SA
    Horm Cancer; 2017 Jun; 8(3):157-165. PubMed ID: 28396979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
    Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
    PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
    Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
    Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).
    Glinskii AB; Glinsky GV; Lin HY; Tang HY; Sun M; Davis FB; Luidens MK; Mousa SA; Hercbergs AH; Davis PJ
    Cell Cycle; 2009 Nov; 8(21):3562-70. PubMed ID: 19838061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
    Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
    Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-surface receptor for thyroid hormone and tumor cell proliferation.
    Davis PJ; Davis FB; Lin HY; Bergh JJ; Mousa S; Hercbergs A; Fenstermaker RA; Ciesielski MJ
    Expert Rev Endocrinol Metab; 2006 Nov; 1(6):753-761. PubMed ID: 30754150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
    Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
    Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.
    Yang YSH; Ko PJ; Pan YS; Lin HY; Whang-Peng J; Davis PJ; Wang K
    J Biomed Sci; 2021 Apr; 28(1):24. PubMed ID: 33827580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.